首頁 > 市場調查報告書 > 製藥

個人化醫學

市場調查報告書

商品編碼

1629643

個人化醫療生物標記市場：按類型、按應用、按最終用戶、按地區

Personalized Medicine Biomarkers Market, By Type, By Application, By End User, By Geography

出版日期: 2024年12月03日 | 出版商:

Coherent Market Insights | 英文 165 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

全球個人化醫療生物標記市場預計到2024年將達到247億美元，預計到2031年將達到681.1億美元，2024年至2031年的複合年成長率為15.6%。

報告範圍		報告詳情
基準年	2023年	2024年市場規模	247億美元
實際資料	2019-2023	預測期	2024-2031
預測 2024-2031 年複合年成長率：	15.60%	2031年價值預測	681.1億美元

圖：2024 年按地區分類的個人化醫療生物標記市場佔有率

個人化醫療生物標記市場是指利用遺傳資訊為患者規劃最佳治療方案。個人化醫療旨在根據個別特徵（例如預測的疾病易感性）設計預防和治療藥物。生物標記在個人化醫療中發揮著重要作用，因為它們有助於確定哪些患者適合特定治療。生物標記可用於篩檢疾病、確定患病風險、預測疾病進展速度以及評估治療反應。基因檢測的可用性不斷提高、慢性病盛行率不斷上升、對精準醫療的日益關注以及技術進步是預計推動全球個人化醫療生物標記市場成長的關鍵因素。

市場動態：

全球個人化醫療生物標記市場的成長是由全球慢性和危及生命的疾病日益流行、製藥公司不斷增加的研發舉措、生物標記在藥物發現和開發中的應用不斷增加、精準度等幾個因素推動的，包括醫療關注的增加、生物標記識別的技術進步以及基因檢測的可用性。然而，與基於生物標記的測試相關的高成本和缺乏報銷政策預計將限制市場成長。由於醫療保健成本上升、個人化醫療意識增強以及醫學研究津貼增加，新興經濟體提供了巨大的市場發展機會。新產品的推出、市場參與企業和研究機構之間的合作以及公司的地理擴大策略是全球個人化醫療生物標記市場的主要商機。

本研究的主要特點

該報告詳細分析了全球個人化醫療生物標記市場，並提供了以2023年為基準年的預測期（2024-2031年）的市場規模和年複合成長率（CAGR%）。

它還揭示了各個細分市場的潛在商機，並說明了該市場有吸引力的投資提案矩陣。

它還提供了有關市場促進因素、限制因素、機會、新產品發布和核准、市場趨勢、區域前景、主要企業採取的競爭策略等的重要見解。

本研究涵蓋的主要企業包括 F Roche Diagnostics、Illumina, Inc.、Thermo Fisher Scientific Inc.、QIAGEN NV、Agilent Technologies, Inc.、Bio-Rad Laboratories, Inc.、Siemens Healthineers、Abbott Laboratories 和 Merck。 Inc.、Myriad Genetics, Inc.、Foundation Medicine, Inc.、Exact Sciences Corporation、Guardant Health、株式會社、Luminex株式會社等

該報告的見解使負責人和公司經營團隊能夠就未來的產品發布、類型升級、市場擴張和行銷策略做出明智的決策。

全球個人化醫療生物標記市場報告針對該行業的各個相關人員相關者，如投資者、供應商、產品製造商、經銷商、新進業者和財務分析師。

透過用於分析全球個人化醫療生物標記市場的各種策略矩陣，促進相關人員的決策。

Roche Diagnostics
Illumina, Inc.
Thermo Fisher Scientific Inc.
QIAGEN NV
Agilent Technologies, Inc.
Bio-Rad Laboratories, Inc.
Siemens Healthineers
Abbott Laboratories
Merck KGaA
Genomic Health, Inc.
Myriad Genetics, Inc.
Foundation Medicine, Inc.
Exact Sciences Corporation
Guardant Health, Inc.
Luminex Corporation

第9章分析師建議

命運之輪
分析師觀點
一致的機會圖

第10章參考文獻與調查方法

參考
調查方法
關於出版商

簡介目錄

Product Code: CMI7566

Global personalized medicine biomarkers market is estimated to be valued at USD 24.70 Bn in 2024 and is expected to reach USD 68.11 Bn by 2031, exhibiting a compound annual growth rate (CAGR) of 15.6% from 2024 to 2031.

Report Coverage		Report Details
Base Year:	2023	Market Size in 2024:	US$ 24.70 Bn
Historical Data for:	2019 To 2023	Forecast Period:	2024 To 2031
Forecast Period 2024 to 2031 CAGR:	15.60%	2031 Value Projection:	US$ 68.11 Bn

Figure. Personalized Medicine Biomarkers Market Share (%), By Region 2024

Personalized Medicine Biomarkers Market - IMG1

Personalized medicine biomarkers market refers to the utilization of genetic information to plan the most suitable treatment for patients. Personalized medicine aims to design preventive or therapeutic products tailored to an individual's characteristics, including their predicted predisposition to illness. Biomarkers play an important role in personalized medicine as they help identify which patients are suitable for specific treatments. Biomarkers can be utilized to screen for diseases, identify the risk of developing a disease, predict the rate of disease progression, and assess the response to treatment. Increasing availability of genetic tests, growing prevalence of chronic diseases, rising focus on precision medicine, and technological advancements are some of the key factors expected to propel the growth of the global personalized medicine biomarkers market.

Market Dynamics:

Global personalized medicine biomarkers market growth is driven by several factors such as growing prevalence of chronic and life-threatening diseases worldwide, rising R&D initiatives by pharmaceutical companies, increasing application of biomarkers in drug discovery and development, growing focus on precision medicine, technological advancements in biomarker identification, and availability of genetic tests. However, high costs associated with biomarker-based tests and lack of reimbursement policies are expected to restrain the market growth. The market players have significant opportunities in developing economies owing to growing healthcare expenditure, rising awareness about personalized medicine, and increasing healthcare research grants. New product launches, collaborations between market players and research institutes, and geographical expansion strategies by companies are some key opportunities in the global personalized medicine biomarkers market.

Key Features of the Study:

This report provides in-depth analysis of the global personalized medicine biomarkers market, and provides market size (USD Bn) and compound annual growth rate (CAGR%) for the forecast period (2024-2031), considering 2023 as the base year

It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market

This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players

Key companies covered as a part of this study include F Roche Diagnostics, Illumina, Inc., Thermo Fisher Scientific Inc., QIAGEN N.V., Agilent Technologies, Inc., Bio-Rad Laboratories, Inc., Siemens Healthineers, Abbott Laboratories, Merck KGaA, Genomic Health, Inc., Myriad Genetics, Inc., Foundation Medicine, Inc., Exact Sciences Corporation, Guardant Health, Inc., and Luminex Corporation

Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics

The global personalized medicine biomarkers market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global personalized medicine biomarkers market

Market Segmentation

Type Insights (Revenue, USD Bn, 2019 - 2031)
- Genetic Biomarkers
- Protein Biomarkers
- Metabolite Biomarkers
Application Insights (Revenue, USD Bn, 2019 - 2031)
- Oncology
- Neurology
- Diabetes
- Autoimmune Diseases
- Cardiology
- Others
End User Insights (Revenue, USD Bn, 2019 - 2031)
- Hospitals
- Diagnostic Laboratories
- Research Institutions
Regional Insights (Revenue, USD Bn, 2019 - 2031)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
Key Players Insights
- Roche Diagnostics
- Illumina, Inc.
- Thermo Fisher Scientific Inc.
- QIAGEN N.V.
- Agilent Technologies, Inc.
- Bio-Rad Laboratories, Inc.
- Siemens Healthineers
- Abbott Laboratories
- Merck KGaA
- Genomic Health, Inc.
- Myriad Genetics, Inc.
- Foundation Medicine, Inc.
- Exact Sciences Corporation
- Guardant Health, Inc.
- Luminex Corporation

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Global Personalized Medicine Biomarkers Market, By Type
- Global Personalized Medicine Biomarkers Market, By Application
- Global Personalized Medicine Biomarkers Market, By End User
- Global Personalized Medicine Biomarkers Market, By Region

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
Driver
Restraint
Opportunity
Impact Analysis
Key Developments
Regulatory Scenario
Product Launches/Approvals
PEST Analysis
PORTER's Analysis
Merger and Acquisition Scenario
Industry Trends

4. Global Personalized Medicine Biomarkers Market, By Type, 2019-2031, (USD Bn)

Introduction
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2020 - 2031
- Segment Trends
Genetic Biomarkers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Protein Biomarkers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Metabolite Biomarkers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

5. Global Personalized Medicine Biomarkers Market, By Application, 2019-2031, (USD Bn)

Introduction
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2020 - 2031
- Segment Trends
Oncology
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Neurology
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Diabetes
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Autoimmune Diseases
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Cardiology
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

6. Global Personalized Medicine Biomarkers Market, By End User, 2019-2031, (USD Bn)

Introduction
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2020 - 2031
- Segment Trends
Hospitals
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Diagnostic Laboratories
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Research Institutions
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

7. Global Personalized Medicine Biomarkers Market, By Region, 2019 - 2031, Value (USD Bn)

Introduction
- Market Share (%) Analysis, 2024,2027 & 2031, Value (USD Bn)
- Market Y-o-Y Growth Analysis (%), 2020 - 2031, Value (USD Bn)
- Regional Trends
North America
- Introduction
- Market Size and Forecast, By Type, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Application, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By End User, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Country, 2019 - 2031, Value (USD Bn)
  - U.S.
  - Canada
Latin America
- Introduction
- Market Size and Forecast, By Type, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Application, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By End User, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Country, 2019 - 2031, Value (USD Bn)
  - Brazil
  - Argentina
  - Mexico
  - Rest of Latin America
Europe
- Introduction
- Market Size and Forecast, By Type, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Application, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By End User, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Country, 2019 - 2031, Value (USD Bn)
  - Germany
  - U.K.
  - Spain
  - France
  - Italy
  - Russia
  - Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, By Type, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Application, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By End User, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Country, 2019 - 2031, Value (USD Bn)
  - China
  - India
  - Japan
  - Australia
  - South Korea
  - ASEAN
  - Rest of Asia Pacific
Middle East
- Introduction
- Market Size and Forecast, By Type, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Application, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By End User, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Country, 2019 - 2031, Value (USD Bn)
  - GCC Countries
  - Israel
  - Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, By Type, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Application, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By End User, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Country/Region, 2019 - 2031, Value (USD Bn)
  - South Africa
  - North Africa
  - Central Africa

8. Competitive Landscape

Roche Diagnostics
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Illumina, Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Thermo Fisher Scientific Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
QIAGEN N.V.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Agilent Technologies, Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Bio-Rad Laboratories, Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Siemens Healthineers
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Abbott Laboratories
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Merck KGaA
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Genomic Health, Inc.
Myriad Genetics, Inc.
Foundation Medicine, Inc.
Exact Sciences Corporation
Guardant Health, Inc.
Luminex Corporation